Table IV.
Multivariate analysis of factors for overall survival after disease recurrence according to breast cancer subtypes.
| Factors | Category | Luminal P-value | Luminal/HER2 P-value | HER2 P-value | Triple-negative P-value |
|---|---|---|---|---|---|
| Menopausal status | Pre-/postmenopausal | 0.046 | 0.10 | 0.35 | 0.70 |
| Tumor size (cm) | <2.0/≥2.0 | 0.52 | 0.17 | 0.007 | 0.21 |
| Nodal status | (−)/(+) | 0.37 | 0.98 | 0.034 | 0.93 |
| Nuclear grade | 1/2/3 | 0.30 | 0.19 | 0.64 | 0.91 |
| Ki-67 value (%) | <20/<50/≥50 | 0.037 | 0.69 | 0.36 | 0.73 |
| DFI (years) | <2/<5/≥5 | <0.0001 | 0.36 | 0.11 | 0.067 |
| Recurrence site | Soft tissue/bone/viscera | 0.004 | 0.57 | 0.08 | 0.008 |
HER2, human epidermal growth factor receptor 2; DFI, disease-free interval.